Novoprotein Scientific Inc. (SHA:688137)
72.49
+3.72 (5.41%)
Sep 1, 2026, 4:00 PM EDT
Novoprotein Scientific Market Cap
Novoprotein Scientific has a market cap or net worth of 5.06 billion as of September 1, 2026. Its market cap has increased by 65.05% in one year.
Market Cap
5.06B
Enterprise Value
4.28B
Revenue
152.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.49
ChartMarket Cap Chart
Since September 29, 2022, Novoprotein Scientific's market cap has decreased from 5.30B to 5.06B, a decrease of -4.42%. That is a compound annual growth rate of -1.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 5.06B | 81.25% |
| Dec 31, 2025 | 2.79B | 20.54% |
| Dec 31, 2024 | 2.32B | -40.46% |
| Dec 29, 2023 | 3.89B | -27.00% |
| Dec 30, 2022 | 5.33B | 0.65% |
| Sep 29, 2022 | 5.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 5.85B |
| PharmaResources (Shanghai) | 5.53B |
| Hangzhou Biotest Biotech | 5.41B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.20B |
| Shenzhen Weiguang Biological Products | 5.15B |
| Boji Medical Technology | 5.07B |
| R&G PharmaStudies | 5.00B |
| Beijing Konruns Pharmaceutical | 4.84B |